Last updated on April 2008

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Irritable Bowel Syndrome
  • Age: Between 18 - 65 Years
  • Gender: Female
  • Other:
    Female from 18 to 65 years of age, inclusive
    Patient experiences recurrent abdominal pain or discomfort at least 3 days per month
    for the last 3 months with symptom onset at least 6 months prior to diagnosis. The
    patient's symptoms must be associated with 1 or more of the following:
    Improvement with defecation
    Onset associated with a change in frequency of stool
    Onset associated with a change in form (appearance) of stool
    Negative serum and urine pregnancy tests
    Completion of at least six days of daily diary assessments using a phone-in
    information system prior to randomization

You may not be eligible for this study if the following are true:

  • Serious underlying diseases, including psychiatric disorders
    Current history of conditions affecting bowel transit
    Recent history of biochemical or structural abnormalities of the gastrointestinal
    tract, gastrointestinal surgery, or gastrointestinal infection
    Clinically significant abnormal examination findings or laboratory tests
    Inability to stop taking certain medications, or a planned change in medications
    (including herbal remedies) which could interfere with study assessments
    Use of drugs and or ethanol which may interfere with compliance of study procedures
    or influence study outcome
    Presence of a medical condition which could interfere with the interpretation of
    tudy data
    Significant use of nicotine or caffeine

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.